The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Sandostatin LAR Market Research Report 2024

Global Sandostatin LAR Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1794949

No of Pages : 67

Synopsis
Octreotide (trade name Sandostatin, among others) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone.
The global Sandostatin LAR market was valued at US$ 1238 million in 2023 and is anticipated to reach US$ 680.3 million by 2030, witnessing a CAGR of -6.8% during the forecast period 2024-2030.
The Sandostatin LAR market analysis reveals a specialized segment within the pharmaceutical industry. Sandostatin LAR is a long-acting formulation of octreotide, a synthetic hormone used to treat various neuroendocrine tumors and acromegaly. The market growth is driven by the increasing prevalence of these conditions and the efficacy of Sandostatin LAR in managing symptoms and slowing tumor growth. Additionally, advancements in drug delivery technologies contribute to its popularity. However, competition from other somatostatin analogs and the high cost of treatment may impact market penetration. Despite challenges, the Sandostatin LAR market holds promise as healthcare providers prioritize personalized and targeted therapies for neuroendocrine disorders, creating opportunities for further development and investment.
This report aims to provide a comprehensive presentation of the global market for Sandostatin LAR, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sandostatin LAR.
Report Scope
The Sandostatin LAR market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sandostatin LAR market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sandostatin LAR manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Segment by Type
500mcg
1000mcg
Other
Segment by Application
Tumors
Bleeding Esophageal Varices
Other
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sandostatin LAR manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sandostatin LAR in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Sandostatin LAR Market Overview
1.1 Product Overview and Scope of Sandostatin LAR
1.2 Sandostatin LAR Segment by Type
1.2.1 Global Sandostatin LAR Market Value Comparison by Type (2024-2030)
1.2.2 500mcg
1.2.3 1000mcg
1.2.4 Other
1.3 Sandostatin LAR Segment by Application
1.3.1 Global Sandostatin LAR Market Value by Application: (2024-2030)
1.3.2 Tumors
1.3.3 Bleeding Esophageal Varices
1.3.4 Other
1.4 Global Sandostatin LAR Market Size Estimates and Forecasts
1.4.1 Global Sandostatin LAR Revenue 2019-2030
1.4.2 Global Sandostatin LAR Sales 2019-2030
1.4.3 Global Sandostatin LAR Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sandostatin LAR Market Competition by Manufacturers
2.1 Global Sandostatin LAR Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sandostatin LAR Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sandostatin LAR Average Price by Manufacturers (2019-2024)
2.4 Global Sandostatin LAR Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sandostatin LAR, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sandostatin LAR, Product Type & Application
2.7 Sandostatin LAR Market Competitive Situation and Trends
2.7.1 Sandostatin LAR Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sandostatin LAR Players Market Share by Revenue
2.7.3 Global Sandostatin LAR Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sandostatin LAR Retrospective Market Scenario by Region
3.1 Global Sandostatin LAR Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sandostatin LAR Global Sandostatin LAR Sales by Region: 2019-2030
3.2.1 Global Sandostatin LAR Sales by Region: 2019-2024
3.2.2 Global Sandostatin LAR Sales by Region: 2025-2030
3.3 Global Sandostatin LAR Global Sandostatin LAR Revenue by Region: 2019-2030
3.3.1 Global Sandostatin LAR Revenue by Region: 2019-2024
3.3.2 Global Sandostatin LAR Revenue by Region: 2025-2030
3.4 North America Sandostatin LAR Market Facts & Figures by Country
3.4.1 North America Sandostatin LAR Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sandostatin LAR Sales by Country (2019-2030)
3.4.3 North America Sandostatin LAR Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Sandostatin LAR Market Facts & Figures by Country
3.5.1 Europe Sandostatin LAR Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sandostatin LAR Sales by Country (2019-2030)
3.5.3 Europe Sandostatin LAR Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sandostatin LAR Market Facts & Figures by Country
3.6.1 Asia Pacific Sandostatin LAR Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sandostatin LAR Sales by Country (2019-2030)
3.6.3 Asia Pacific Sandostatin LAR Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Sandostatin LAR Market Facts & Figures by Country
3.7.1 Latin America Sandostatin LAR Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sandostatin LAR Sales by Country (2019-2030)
3.7.3 Latin America Sandostatin LAR Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sandostatin LAR Market Facts & Figures by Country
3.8.1 Middle East and Africa Sandostatin LAR Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sandostatin LAR Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sandostatin LAR Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sandostatin LAR Sales by Type (2019-2030)
4.1.1 Global Sandostatin LAR Sales by Type (2019-2024)
4.1.2 Global Sandostatin LAR Sales by Type (2025-2030)
4.1.3 Global Sandostatin LAR Sales Market Share by Type (2019-2030)
4.2 Global Sandostatin LAR Revenue by Type (2019-2030)
4.2.1 Global Sandostatin LAR Revenue by Type (2019-2024)
4.2.2 Global Sandostatin LAR Revenue by Type (2025-2030)
4.2.3 Global Sandostatin LAR Revenue Market Share by Type (2019-2030)
4.3 Global Sandostatin LAR Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sandostatin LAR Sales by Application (2019-2030)
5.1.1 Global Sandostatin LAR Sales by Application (2019-2024)
5.1.2 Global Sandostatin LAR Sales by Application (2025-2030)
5.1.3 Global Sandostatin LAR Sales Market Share by Application (2019-2030)
5.2 Global Sandostatin LAR Revenue by Application (2019-2030)
5.2.1 Global Sandostatin LAR Revenue by Application (2019-2024)
5.2.2 Global Sandostatin LAR Revenue by Application (2025-2030)
5.2.3 Global Sandostatin LAR Revenue Market Share by Application (2019-2030)
5.3 Global Sandostatin LAR Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Sandostatin LAR Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Sandostatin LAR Product Portfolio
6.1.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sandostatin LAR Industry Chain Analysis
7.2 Sandostatin LAR Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sandostatin LAR Production Mode & Process
7.4 Sandostatin LAR Sales and Marketing
7.4.1 Sandostatin LAR Sales Channels
7.4.2 Sandostatin LAR Distributors
7.5 Sandostatin LAR Customers
8 Sandostatin LAR Market Dynamics
8.1 Sandostatin LAR Industry Trends
8.2 Sandostatin LAR Market Drivers
8.3 Sandostatin LAR Market Challenges
8.4 Sandostatin LAR Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’